Latest Insider Transactions at Tonix Pharmaceuticals Holding Corp. (TNXP)
This section provides a real-time view of insider transactions for Tonix Pharmaceuticals Holding Corp. (TNXP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tonix Pharmaceuticals Holding Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tonix Pharmaceuticals Holding Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2022
|
Seth Lederman Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
20,000
+45.21%
|
$20,000
$1.71 P/Share
|
|
Mar 25
2022
|
Seth Lederman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+47.13%
|
$0
$0.24 P/Share
|
|
Sep 28
2021
|
Seth Lederman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+49.63%
|
$0
$0.61 P/Share
|
|
May 25
2021
|
Daniel Wintner Goodman Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$5,000
$1.12 P/Share
|
|
Mar 24
2021
|
Seth Lederman Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
16,733
+11.03%
|
$16,733
$1.32 P/Share
|
|
Jan 07
2021
|
Gregory M Sullivan Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,322
+39.71%
|
$0
$0.51 P/Share
|
|
Dec 30
2020
|
Seth Lederman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
35,000
+22.84%
|
$0
$0.68 P/Share
|